UNLV rocketry team shoots for the sky
LAS VEGAS (KLAS) — Most college students spend their weekends cutting loose or occasionally studying. But a group of UNLV engineering students uses their free time to aim a little higher.
On a Saturday morning in April, the university's chapter of Students for the Exploration and Development of Space, or SEDS, gathered at the Jean Dry Lake Bed to put a year's worth of work to the test, launching a rocket more than 10,000 feet into the sky.
The project is led by Riley Santiago, a third-year engineering student at UNLV.
'When we see this successfully launch, I'm just going to feel a real sense of pride,' Santiago said.
Just a few years ago, Santiago was on a path toward medical school. Today, he's leading a team of students preparing to compete in the International Rocket Engineering Competition (IREC) in June. It's a contest that pits top university rocketry clubs from around the world against each other.
This test flight was their only chance to see how their design would perform under real conditions.
'This is kind of the biggest moment of the year other than the actual competition,' said student Ty Huel, who oversees the rocket's recovery systems.
The rocket's design requires that every component, from its GPS unit to its parachutes, work flawlessly to ensure a safe and intact return. The payload, a small tank of water meant to simulate a fuel device, also housed several onboard cameras to record the flight.
The team spent the morning racing to meet their noon launch deadline, carefully assembling the rocket and troubleshooting last-minute problems.
Problems started with the payload. It's the part of the rocket that holds a small tank of water. As part of the competition, SEDS UNLV is trying to minimize water sloshing during launch, mimicking fuel flow.
'It's complicated stuff,' Santiago admitted. 'We run a lot of calculations beforehand, but there's always something unexpected.'
Despite the pressure, Santiago praised his teammates for staying calm and focused. 'I love everyone here. They're really passionate, and we all get along well. That makes a big difference when you're under this kind of pressure.'
After several hours of preparation, the team was finally ready.
At around 2:15 p.m., with the rocket standing tall on the launchpad, Santiago received the green light to initiate the countdown. He pressed a red button, and seconds later, the rocket blasted into the sky.
'It's happening!' Santiago shouted, overwhelmed with excitement as the rocket soared.
The SEDS rocket reached 9,700 feet, just shy of its 10,000-foot target. However, it fell to Earth gently after the parachutes deployed.
'Success. Absolute success,' Santiago said, beaming. 'I'm very happy right now. Yeah, I could cry.'
With the test flight complete, the team will now analyze the flight data and refine their rocket for the IREC competition, which starts June 9 in Midland, Texas. More than 200 teams from around the world will take part.
Whether or not they bring home a trophy, Santiago says the experience of seeing their hard work pay off is reward enough.
'Just seeing your work succeed—after putting in so much effort—is crazy,' he said. 'That's what I love about this club.'
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
5 days ago
- Medscape
Funding Gaps Threaten Genomic Advances in Latin America
In Latin America, efforts to implement preventive strategies, diagnostic tools, and personalized treatment for patients with rheumatic diseases often face significant barriers. However, there have been promising developments, many of which have been driven by the growing field of genomic medicine. One such initiative is the Ibero-American Research Consortium on the Genetics of Rheumatic Diseases (IARGE-RD). The project collected more than 3000 DNA samples from patients with rheumatoid arthritis and healthy individuals across multiple countries. The aim is to reach 5000 samples by 2026. 'Obtaining genomic data from Latin American populations is crucial because it allows us to better understand the genetic and clinical characteristics of these populations. Currently, most genetic data comes from European populations, which limits the ability to extrapolate the results obtained,' said Roberto Díaz Peña, PhD in Biochemistry, principal investigator at the Health Research Institute of Santiago de Compostela in Spain, where he conducts research as a Miguel Servet Researcher affiliated with the Fundación Pública Galega de Medicina Xenómica. He also served as an associate researcher at the Universidad Autónoma de Chile, Talca, Spain, and told Medscape Spanish. The goals and vision of the IARGE-RD are detailed in an article published in The Journal of Rheumatology . The consortium aims to foster the development and implementation of precision medicine strategies to address inequities faced by patients with rheumatic diseases in Latin America. The authors emphasized that achieving this goal would require collaborative efforts in the region, involving various sectors interested in increasing the use of genomic medicine in clinical practice. Gabriela Ortiz Cruz, PhD, a specialist in genetics, is actively contributing to these efforts. She is the founder, lead researcher, and professor at the Center for Research in Genetics and Genomics, Autonomous University of Coahuila, Saltillo, Mexico. The center is based at Dr Gonzalo Valdés Valdés University Hospital of Saltillo, Saltillo, Mexico, where she has advanced research and education in genetics and genomics. Although she was not directly involved in the IARGE-RD, Ortiz Cruz emphasized the project's importance for Latin America. She noted that it addressed key regional challenges, including genomic representation, equitable access to diagnostic tools, the potential for personalized prevention and treatment, and the need for interdisciplinary collaboration. 'For me, the Ibero-American Research Consortium on the Genetics of Rheumatic Diseases represents a significant step toward equity in precision medicine and the decentralization of genetic research. It is an initiative that not only addresses scientific needs but also has the potential to transform the quality of life of people in the region,' said Ortiz Cruz. Despite its promise, the consortium faces a major obstacle: A lack of sustained funding. The initiative was launched in 2022 with the support of Chile's National Fund for Scientific and Technological Development. Initially a collaboration between Chile and Spain, the initiative grew rapidly and expanded to include contributors from other Latin American countries. Currently, healthcare professionals from a wide range of centers in Argentina, Brazil, Chile, Peru, Colombia, Costa Rica, and Mexico actively collaborate in this study. The current research focuses on rheumatoid arthritis and spondyloarthropathies, primarily because these are the conditions for which funding has been secured. However, the consortium plans to broaden its scope to include other rheumatic diseases. 'We have financial support from Chile's National Agency for Research and Development; however, expanding the project to include other neighboring countries and additional rheumatic diseases will require more funding and an increased number of collaborations,' said Díaz Peña. According to Díaz Peña, the main challenge in this region is the lack of sufficient funding to conduct large-scale genomic studies. He emphasized that long-term financial support from research agencies, academic institutions, and private partners is essential for a project's success. Ortiz Cruz echoed this concern, pointing to lack of funding as one of the most pressing issues for research initiatives in Latin America. 'In Latin America, financial resources allocated to research are generally limited, and other areas of public health are often prioritized over genomic research. Furthermore, many genomic research projects depend on international funding, which is not always consistent, creating instability or uncertainty regarding continuity,' he said. He added that 'to overcome this obstacle, public-private partnerships could be created and government policies that prioritize health research could be promoted, while also promoting awareness campaigns about the return on investment in genomics. The latter would justify greater budget allocations.' Can Latin America Lead the Way in Genomic Medicine? Despite these challenges, Ortiz Cruz believes that Latin America is well positioned to become a global leader in genomic and precision medicine. The region's rich genetic diversity, shaped by Indigenous, African, European, and Asian ancestries, offers a unique opportunity to study genetic variants, gene-environment interactions, and disease susceptibility patterns that might not be evident in other populations. Furthermore, it is associated with a high incidence of autoimmune, metabolic, infectious, and chronic diseases. These conditions are amenable to genomic research and the extraction of specific biomarkers, with the aim of finding solutions tailored to the local needs of the population. In addition, she highlighted that the region has a growing community of researchers who are highly trained and motivated to develop innovative and relevant strategies in their environment. 'All of these aspects position Latin America as fertile ground for the advancement of genomic research. By leveraging these strengths and overcoming challenges, the region can become a global leader in precision medicine tailored to diverse populations,' said Ortiz Cruz. Ortiz Cruz urged regional leaders not to miss this opportunity and to invest in and support research projects in genomic medicine. 'This is a crucial moment to make visionary decisions that will not only transform the way we understand and treat diseases but will also leave a legacy of innovation and equity for future generations. The impact will be tangible, measurable, and transcendental for the well-being of all,' said Ortiz Cruz. Looking ahead, the IARGE-RD plans to expand its reach by 2025, inviting more countries to join and strengthening their collaborations with genomic research groups across Latin America and beyond. 'We certainly invite all clinical and basic researchers interested in expanding their knowledge of genomics applied to rheumatic diseases in Latin America to join the Ibero-American Research Consortium on the Genetics of Rheumatic Diseases. Our goal is to create a strong and diverse collaborative network,' Díaz Peña concluded. All authors reported no relevant financial relationships. Díaz Peña and Ortiz Cruz declared having no relevant financial relationships.

Associated Press
23-05-2025
- Associated Press
Las Vegas STEM Pipeline Initiative Reaches Over 500 Students, Empowering the Next Generation of STEM Leaders
05/23/2025, Las Vegas, NEVADA // KISS PR Brand Story PressWire // FOR IMMEDIATE RELEASE Las Vegas STEM Pipeline Initiative Reaches Over 500 Students, Empowering the Next Generation of STEM Leaders LAS VEGAS, NV — The Las Vegas STEM Pipeline Initiative, supported by the Adair Family Foundation, has successfully engaged more than 500 local students through comprehensive STEM outreach and mentorship programs from February to April 2025. In collaboration with the UNLV Kirk Kerkorian School of Medicine and Roseman University, the initiative delivers hands-on STEM experiences, targeted mentorship, and innovative AI-driven tools for personalized student pathways. The program focuses on increasing STEM awareness, supporting educational partnerships, and removing barriers for Las Vegas students pursuing STEM careers. The Las Vegas STEM Pipeline Initiative underscores the importance of community-supported pathways in science, technology, engineering, and mathematics, emphasizing inclusivity and opportunity for all Las Vegas students. For more information, please visit: Media Contact: Dr. Luther Adair II Las Vegas STEM Pipeline Initiative [email protected] (725)567-4241
Yahoo
15-05-2025
- Yahoo
Guelph General Hospital adds digital pathology to cloud service from Sectra--enables integrated diagnostics for improved patient care
LINKÖPING, Sweden and MISSISSAUGA, ON, May 15, 2025 /PRNewswire/ -- International medical imaging IT and cybersecurity company Sectra (STO: SECT B) announces that Guelph General Hospital in Canada will be the first in the country to add Sectra's digital pathology module to its current cloud service, Sectra One Cloud. This addition will provide pathologists with instant access to images and facilitate cross-departmental collaboration around patient cases. The service will enhance workflow efficiency and ultimately contribute to improved patient care. "By adding digital pathology into our existing system, we will improve quality of patient care, by enhancing diagnostic accuracy, precision, workflow and turnaround times. It will significantly enhance collaboration between our radiology and pathology teams, and we are confident that this unified approach will lead to better patient outcomes and improved care," says Dr. Chris Ma, Chief of Pathology & Laboratory Medicine at Guelph General Hospital. Guelph General Hospital will complement their use of microscopes with a digital solution, allowing the pathologists to enhance review and collaboration around cases as well as benefit from AI tools. The digital workflow provides instant and, when needed, remote access to digital images of tissue samples instead of relying on physical glass slides reviewed in microscopes. With their pathologists and radiologists now sharing a unified system, it will pave the way for integrated diagnostics, which makes collaboration across different specialties more effective. "Collaboration across specialties is vital. It is especially essential when addressing complex cases, like cancer, for example. Being the first in Canada to adopt Sectra's cloud service and now the digital pathology module, Guelph General Hospital is yet again leading the way in advancing Canadian healthcare. We look forward to further supporting them in their ongoing digital healthcare transformation journey," says Nader Soltani, President of Sectra in Canada. Guelph General Hospital extended its existing cloud service contract, established in October 2023, with Sectra's digital pathology module in April 2025. The pathology module is part of Sectra's enterprise imaging solution, which provides a unified strategy for all imaging needs in one single system thus both improving outcomes as well as lowering operational costs. The scalable and modular solution, with a VNA at its core, allows healthcare providers to grow from ology to ology and from enterprise to enterprise without acquiring a new back end. Visit Sectra's website to read more about Sectra and why it's top-ranked in "Best in KLAS". About Sectra Sectra contributes to a healthier and safer society by assisting health systems throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. The company, founded in 1978, is headquartered in Linköping, Sweden, with direct sales in 19 countries, and distribution partners worldwide. Sales in the 2023/2024 fiscal year totaled SEK 2,964 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra's website. About Guelph General Hospital Guelph General Hospital (GGH) is a dynamic, comprehensive acute care facility providing a full range of services to the residents of Guelph and Wellington County. Services include 24-hour emergency coverage, advanced technology and diagnostic support, and specialty programs. GGH is a regional provider of general vascular surgery and a designated provincial Bariatric Centre of Excellence. GGH is also a proud partner in the Guelph Wellington Ontario Health Team. Visit Guelph General Hospital online at or @guelphgeneral. For further information, please contact:Dr. Torbjörn Kronander, CEO and President Sectra AB, +46 (0)705 23 52 27Marie Ekström Trägårdh, Executive Vice President Sectra AB and President Sectra Imaging IT Solutions, +46 (0)708 23 56 10 This information was brought to you by Cision The following files are available for download: Sectra Digital Pathology View original content: SOURCE Sectra Sign in to access your portfolio